Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
News-Medical.Net on MSN
New approach harnesses tumor's own machinery to produce immune-stimulating molecules
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
ZME Science on MSN
COVID-19 Vaccines Have an Unexpected Side Effect: They Help the Immune System vs Cancer
Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...
Myeloid cells mediate interferon-driven resistance to immunotherapy inadvanced renal cell carcinomaPublication: Immunity - ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but ...
LAWRENCEVILLE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback